These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39029506)

  • 1. Drug Resistance in Biofilm and Planktonic Cells of
    Montoya-Hinojosa EI; Villarreal-Treviño L; Bocanegra-Ibarias P; Camacho-Ortiz A; Flores-Treviño S
    Microb Drug Resist; 2024 Sep; 30(9):354-362. PubMed ID: 39029506
    [No Abstract]   [Full Text] [Related]  

  • 2. Biofilm Eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-Sulfamethoxazole.
    Río-Chacón JMD; Rojas-Larios F; Bocanegra-Ibarias P; Salas-Treviño D; Espinoza-Gómez F; Camacho-Ortiz A; Flores-Treviño S
    Jpn J Infect Dis; 2024 Jul; 77(4):213-219. PubMed ID: 38296539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antimicrobials on
    Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
    Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole on
    Montoya-Hinojosa EI; Salazar-Sesatty HA; Alvizo-Baez CA; Terrazas-Armendariz LD; Luna-Cruz IE; Alcocer-González JM; Villarreal-Treviño L; Flores-Treviño S
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):213-223. PubMed ID: 36625029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
    J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH; Yu CM; Hsu ST; Wu RX
    J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
    Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multilocus sequence analysis, biofilm production, antibiotic susceptibility and synergy tests of Burkholderia species in patients with and without cystic fibrosis].
    Akışoğlu Ö; Engin D; Sarıçam S; Müştak HK; Şener B; Hasçelik G
    Mikrobiyol Bul; 2019 Jan; 53(1):22-36. PubMed ID: 30683036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
    Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
    Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E; Pongrácz J; Iván M; Kristóf K
    Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
    Lee YL; Liu CE; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
    Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
    Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z; Qin J; Liu Y; Li C; Ying C
    BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
    Wu K; Yau YC; Matukas L; Waters V
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
    Karamanlıoğlu D; Dizbay M
    Turk J Med Sci; 2019 Apr; 49(2):683-686. PubMed ID: 30866602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.